Adrian Ruiz-Acuna
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
RBM10 loss induces aberrant splicing of cytoskeletal and extracellular matrix mRNAs and promotes metastatic fitness.
Journal: bioRxiv : the preprint server for biology
Published: July 19, 2024
RBM10 loss promotes metastases by aberrant splicing of cytoskeletal and extracellular matrix mRNAs.
Journal: The Journal of experimental medicine
Published: June 14, 2024
Comprehensive Mass Spectral Libraries of Human Thyroid Tissues and Cells.
Journal: Scientific data
Published: April 22, 2024
Genomic and epigenomic profile of thyroid cancer.
Journal: Best practice & research. Clinical endocrinology & metabolism
Published: April 24, 2022
Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer.
Journal: Cellular and molecular life sciences : CMLS
Published: January 04, 2022
Identification of an interactome network between lncRNAs and miRNAs in thyroid cancer reveals SPTY2D1-AS1 as a new tumor suppressor.
Journal: Scientific reports
Published: October 14, 2021
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice.
Journal: Journal of visualized experiments : JoVE
Published: September 10, 2019
Regulators of the RAS-ERK pathway as therapeutic targets in thyroid cancer.
Journal: Endocrine-related cancer
Published: April 09, 2019
Genomic reprograming analysis of the Mesothelial to Mesenchymal Transition identifies biomarkers in peritoneal dialysis patients.
Journal: Scientific reports
Published: October 11, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026